Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.41+0.11 (+1.33%)
Close on Nov 17, 2026Market cap $488.95MP/E –Yield –
Capricor Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Capricor Therapeutics's price to book ratio was 2.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.8× to 61.1×, with a median of 6.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −13.1 |
| 2025 | Dec 31, 2025 | 15.7× | +7.6 |
| 2024 | Dec 31, 2024 | 8.2× | −18.4 |
| 2023 | Oct 31, 2023 | 26.6× | +20.4 |
| 2022 | Dec 30, 2022 | 6.2× | +4.3 |
| 2021 | Dec 31, 2021 | 1.9× | −0.4 |
| 2020 | Dec 31, 2020 | 2.3× | +0.8 |
| 2019 | Dec 31, 2019 | 1.5× | −0.3 |
| 2018 | Dec 31, 2018 | 1.8× | −20.7 |
| 2016 | Jan 29, 2016 | 22.5× | −3.4 |
| 2015 | Dec 31, 2015 | 25.9× | +15.3 |
| 2013 | Apr 30, 2013 | 10.6× | −64.2 |
| 2012 | Oct 31, 2012 | 74.7× | −33.5 |
| 2011 | Dec 30, 2011 | 108.3× | – |
See a number that looks wrong?